Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Greenwood Sejahtera Tbk. (GWSA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Greenwood Sejahtera Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Greenwood Sejahtera Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Greenwood Sejahtera Tbk. diperdagangkan di Rp167 (kapitalisasi pasar 1,34 T, volume 24 jam 929,4 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Greenwood Sejahtera Tbk. jauh lebih besar — sekitar 8,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Greenwood Sejahtera Tbk. lebih aktif diperdagangkan (929,4 rb vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.

GWSAOBAT
Kapitalisasi Pasar
1,34 T166,01 M
Volume
929,4 rb324 rb
Lot
9,29 rb3,24 rb
Perputaran
156,04 jt77,68 jt
Harga Rata-rata
167,89239,75
Nilai Transaksi
156,04 jt77,68 jt
Harga Ekuilibrium Indikatif
167240
Volume Ekuilibrium Indikatif
151

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

GWSA
Lihat detail
OBAT
Lihat detail

Tentang Greenwood Sejahtera Tbk.

Greenwood Sejahtera is part of KG Global Development. On the begining, the company have a relation with Jababeka group, which own the land that has been used to builit TCC Batavia.PT Greenwood Sejahtera, company that developing The City Center Batavia (TCC Batavia), on December 23, 2011. The City Center Batavia is a superblock, mix used development project on top of 2,1 hectares of land. Its first tower is a skycrapper building: a tower with 46 storey, plus an 8 storey annex. According to the masterplan, Greenwood Sejahtera will build 3 tower on the site. The other tower will be completed in 2017 and the area will be expanded to 5.4 hectares. Its ground breaking ceremony is on September 12, 2009.

Selengkapnya di halaman GWSA

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT